Health Related Quality of Life: Cancer cachexia. Professor Graeme D. Smith Editor Journal of Clinical Nursing CMU,Taiwan August 2017

Size: px
Start display at page:

Download "Health Related Quality of Life: Cancer cachexia. Professor Graeme D. Smith Editor Journal of Clinical Nursing CMU,Taiwan August 2017"

Transcription

1 Health Related Quality of Life: Cancer cachexia Professor Graeme D. Smith Editor Journal of Clinical Nursing CMU,Taiwan August 2017

2 Overview to lecture Introduction/Scotland Patient related outcome measures (PROM s) Health related quality of life HRQoL) measures Psychometrics Cancer cachexia Assessment of cancer cachexia Nursing/healthcare implications

3 Cancer cachexia

4 Davidson C & Smith GD (2005) Cachexia and its management. Cancer Nursing Practice (March suppl.) Cancer cachexia

5 Editor JCN

6

7 Scotland Edinburgh Napier University

8

9

10

11

12 The meaning of QoL is difficult to define: Quality of Life: Definition the possession of the resources necessary to the satisfaction of individual needs, wants and desires, participation in activities enabling personal development and selfactualisation and comparison between oneself and others Shin and Johnson, 1978

13 What is quality of life?

14 World Health Organization: Definition of Health (1948) "a state of complete physical, mental, and social well-being, and not merely the absence of disease and infirmity".

15 Health Related Quality of Life Definition: The functional impact of an illness and its consequent therapy upon the patient, as perceived by the patient. Shipper et al. (1990)

16 Health related quality of life: Historical Perspective 1940 s Equated with goodness of life 1960 s socio-economic status (i.e. unemployment) 1970 s subjective issues (i.e. family life, health) 1975 Term QoL appears in Index Medicus s onwards Development of Medical and Nursing indicators

17 The nature of research evidence Patient evidence Clinical evidence High quality patient care (Relevant, effective, acceptable, appropriate) Economic evidence Acknowledgement: Dr Sophie Staniszewska, RCN Research Institute, University of Warwick

18 Patient voice evidence

19 Cancer cachexia: Quality of Life Patient reported outcomes measures (PRMO) measure of patients health Health related quality of life (HRQoL) a PROM concerned with health aspects of patient Important in cancer cachexia survival in inappropriate form of assessment Need for HRQoL tools in cancer cachexia

20 Patient reported outcome measures: PROMs HRQoL Utility Symptoms Satisfaction Behaviour Utilization

21 What is a PROM? Patient-reported outcomes measure (PROM) represent the patient s report of a health condition and its treatment (Acquadro et al. Value in Health 2003;5: ) Any report coming directly from patients (i.e., study subjects) about a health condition and its treatment (FDA Draft PRO Guidance)

22 Health Outcomes: different perspectives Clinical Perspective Patient Perspective Subjective health status Health related quality of life Satisfaction Societal Perspective Utilization Cost

23 The value of patient evidence What insights does patient evidence offer us? Personal impact of living with a condition and experience of care People s preferences and values Outcomes that patients want from treatment or care Impact of treatment or care on outcome, symptoms, physical and social functioning, quality of life Risks, benefits and acceptability of a treatment or service Equality issues and considerations for specific sub-groups

24 Health Related Quality of Life: Beware of questionnaire copyright

25

26 Psychometrics: key references Bannigan, K. and Watson, R (2009), Reliability and validity in a nutshell. Journal of Clinical Nursing, 18: DeVon HA, Block ME, Ernst DM et al. (2007) A Psychometric Toolbox for Testing Validity and Reliability. Journal of Nursing Scholarship (2 nd Quarter):

27 Psychometrics: HRQoL Psychometrics What evidence is there that subjective judgements form a sound basis for measuring health? Can subjective data be more than just a crude approximation of health? Do HRQoL measures merely affix numbers to quantitative subjective judgements? Psychometrics describe the science of assigning numerical scores to subjective judgements

28 Evaluation HRQoL: Psychometrics Psychometric assessment involves evaluation of the following: Validity Reliability Sensitivity Specificity Before achieving acceptance as a valid diagnostic tool or evaluative yardstick in disease assessment psychometric testing must be undertaken.

29 Quality of HRQoL: Psychometrics Validity Extent to which a tool measure what it is intend to A quantitative assessment of how well an index measures the phenomenon of interest Criterion Validity Comparison of a new index vs. the gold standard Discriminant validity Extent to which scores of a measurement distinguish between individuals that should differ (in health). Content Validity Measures the degree to which the index measures the full spectrum of problems caused by a specific disease

30 Quality of HRQoL measures: Psychometrics Concurrent Validity Validity indicated by comparing scores on a measurement with those obtained by applying alternative, similar measures at same time. Construct Validity Used when there is no criterion to evaluate the validity of a measure against. i.e. compares a new index with a hypothesis Convergent validity The extent to which two or more instruments that claim to measure the same topic agree with each other.

31 Quality of HRQoL measures: Reliability Reliability Consistency of an index when re-administered under similar conditions on separate occasions The reliability of an instrument is the degree of consistency with which the instrument measures the attribute in question Reliability refers to the stability of a measurement Will it give the same results on separate occasions

32 Quality of HRQoL measures: psychometrics Sensitivity Ability of a measurement tool identify those who have a condition % of all cases with a condition who are detected by the measure Specificity Ability of a measrue to correctly identify those who do NOT have a condition The word specificity refers to how narrowly a test is targeted i.e. does it only identify people with a specific disease?

33 Quality of HRQoL measures Analogue of an Archer: An archer must learn to hit the centre of the target. Then he/she must be able to hit the centre consistently=good archer. Validity and reliability of HRQoL can be thought of in a similar way.

34 HRQoL measurement scales: Psychometrics

35 What Health Outcomes are Important? What we want to know. How much the intervention improves health people involved? What outcomes/factors should we be looking at? Types of Outcome.. Cure? Progression-free? Improved measurement? (e.g. pain management) Reduction of risk? (e.g. malnutrition) Improved quality of life? Tools to measure health related quality of life (HRQoL) were developed and are available in a wide range of areas of health

36 Types of Health Measurement Tool In an attempt to capture health a number of tools have been designed: Generic (preference based) compared across diseases? Comparable across different diseases SF-36 Disease Specific measures changes within a particular disease or area. Limited can only calculate within a disease QLQ CA30 Add-on disease add on to a generic tool. (EQ-5D add-on) 36

37 Examples of HRQoL Measures Generic (disease non-specific) EQ-5D EuroQol 5 Dimension SF-6D and SF-36 Short-Form Disease Specific EORTC QLQ-C30 -European Organization for Research and Treatment of Cancer Quality of Life Questionnaire EORTC QLQ-CAX24 Cancer cachexia Add-On Tools EQ-5D+C add on for cognitive factors 37

38 Describing Health State Using EQ-5D Mobility I have no problems in walking about I have some problems in walking about I am confined to bed Self-care I have no problems with self care I have some problems washing or dressing myself I am unable to wash or dress myself Usual activities (e.g. work, study, housework, family or leisure activities) I have no problems with performing my usual activities I have some problems with performing my usual activities I am unable to perform my usual activities Pain/discomfort I have no pain or discomfort I have moderate pain or discomfort I have extreme pain or discomfort Anxiety/depression I am not anxious or depressed I am moderately anxious or depressed I am extremely anxious or depressed

39 EQ-5D VAS

40

41 Valuing Health States Using EQ-5D EQ-5D defines 243 possible states: Values of states elicited from UK general population (n=3,395) Has been developed in different countries for that specific population Mean values can be used in economic evaluations Values elicited using time trade-off QUALY so 1year in perfect health = 2 years in 0.5 health Now a version for children language has changed: anxious/depressed sad/worried/unhappy Work/housework school/playing/sports

42 Measuring health related quality of life Using HRQoL measures in clinical setting: 1. Prioritise problems 2. Facilitate communication 3. Screen for potential problems 4. Identify preferences 5. Monitor changes/ Responses to treatment 6. Train new staff 7. Clinical audit 8. Clinical governance Higginson & Carr (2001) Carr AJ and J Higginson I J (2001)Measuring quality of life: Are quality of life measures patient centred? BMJ,322(7298):

43

44 Cancer cachexia: Quality of Life

45 Cancer cachexia: Quality of Life Most widely used HRQoL scales in oncology: 1. FACT-G Functional Assessment of Cancer Therapy (FACT-G) AND 2. EORTC-QLQC30 European Organization for Treatment of Cancer Quality of Life Questionnaire

46 Cancer cachexia: Quality of Life

47 QLQ EORTC 30

48 QLQ EORTC 30 Five Multi-item scales: 1. physical 2. role 3. social 4. emotional 5. cognitive functioning Nine single items: 1. pain 2. fatigue 3. financial impact 4. appetite loss, 5. nausea/vomiting 6. diarrhoea, 7. constipation, 8. sleep disturbance 9. quality of life

49 Critique of cancer tools Inadequacy of current tools Most relevant & important HRQOL issues not covered by EORTC QLQ C30 or FACT G FAACT methodological flaws in development & fails to address social impact Specifically Measure HRQoL in Cancer cachexia?

50 Cancer cachexia

51 Cancer cachexia: Quality of Life Definition Cancer cachexia is a multi-facted syndrome Defined by on-going loss of skeletal muscle mass (with or without loss of fat mass) Cannot be reversed by conventional nutritional support Leads to progressive functional impairment

52 Cancer cachexia: Quality of Life

53 Cancer cachexia: Quality of Life

54 Cancer cachexia: Quality of Life Cachexia has a profound negative effect on: Treatment Survival Clinical burden Psychosocial factors Health related quality of life No standard of care or approved drugs

55 Cancer cachexia: Quality of Life

56 Cancer Cachexia: Quality of Life EPCRC guidelines

57 Cancer cachexia: Quality of Life EPCRC diagnostic criteria

58 Cancer cachexia: Quality of Life

59 Cancer cachexia: Treatment

60

61 Cachexia: Quality of Life

62 Cachexia: Quality of Life

63

64 Cachexia: Quality of Life FAACT

65 Cachexia: Quality of Life G8 Screening Tool

66 Cachexia: Quality of Life MNA Short form

67 Cancer cachexia: Quality of Life Malnutrition Screening Tool (MST)

68 Cancer cachexia: Quality of Life Malnutrition Screening Tool (MST)

69 Cancer cachexia: Quality of Life Edmonton Symptoms Assessment System

70 Cancer cachexia: Quality of Life Patient-generated subjective global status

71 Cancer cachexia: Quality of Life Nutrition impact symptoms

72 Cancer Cachexia: Quality of Life FAACT

73 Cachexia: Quality of Life FAACT

74 Cancer cachexia: Quality of Life Key reference: Wheelwright SJ et al. (2017) Development of the EORTC QLQ-CAX24: A questionnaire for cancer patients with cachexia. Journal of Pain and Symptom Management Vol. 53 No. 2 pp

75 Cancer cachexia: Quality of Life No standard of care or approved drugs Cachexia common problem for cancer patient Incidence of cachexia in cancer 50-80% Accounts for 20% of cancer deaths

76 Impact of cancer cachexia

77 Cancer cachexia: Quality of Life Methods for development of EORTC QLQ-CAX24 Approved by EORTC Quality of Life group Supplement the EORTC QLQ-C30 Involved several European countries Coordinated UK (University of Southampton) Ethical & research governance approval in each country Four distinct phases (Phases 1-4)

78 Cancer cachexia: Quality of Life Methods for development of EORTC QLQ-CAX24 Phase One: HRQoL in cachexia generated interviews with patients & HCP s Supplemented with literature search Phase Two: HRQoL issues reviewed and revised Questionnaire items formulated

79 Cancer cachexia: Quality of Life Methods for development of EORTC QLQ-CAX24 Phase Three: Questionnaire items are pilot tested face/content validity & acceptability Provisional version of QLQ-CAX developed Phase Four: New questionnaire field tested Still to be reported by EORTC QLG

80 Cancer cachexia: Quality of Life Methods for development of EORTC QLQ-CAX24 Eligibility criteria for participants: Confirmed cancer diagnosis Consensus definition of cancer cachexia Over the age of eighteen years old Able to participate in interview Able to complete self-report questionnaire

81 Cancer cachexia: Quality of Life Phase two: Results Patient comments lead to inclusion 2 items: too tired to eat being in too much pain to eat Thirteen items removed Result of decision rules from module guidelines Total items to be considered Phase 3 = 44

82 Cachexia: Quality of Life Phase Three: Results Total 110 patients were recruited Wording changed Have you worried that your weight might lose your independence? Have you worried about becoming more dependent on others? Item Have you felt hungry?- removed as ambiguous Appetite loss covered by QLQ-C30

83 Cachexia: Quality of Life Examples deleted (20 items) No hunger (scoring ambiguity) Changeable appetite Thinks a lot about food and eating Uncomfortable with sexual intimacy Lack of support from HCP s Worried about weight loss

84 Cancer cachexia: Quality of Life Provisional module has 24 items EORTC QLQ-CAX-24 Five multi-item sub-scales proposed Food aversion Eating and weight loss worry Eating difficulties Loss of control Physical decline

85 Cancer cachexia: avoiding food

86 Cancer cachexia: Quality of Life Example of sub-scale: Food aversion Taste change Texture of food unpleasant Putting off eating by food smells Putting off eating by quantity Feeling too full to eat (Cronbach s alpha 0.72)

87 Cancer cachexia: Quality of Life Example of sub-scale: Eating difficulties Willing but not able to eat Difficulty drinking Difficulty swallowing (Cronbach s alpha 0.62)

88 Cachexia CAX-24: Quality of Life

89

90 Summary: Cachexia CAX-24 The EORTC QLQ-CAX24 provides an: Relevant tool for cancer cachexia Acceptable with cancer cachexia patients Applicable for assessment of cancer cachexia Suitable for clinical practice (research) Provide evidence of patient perceived benefit

91 Cancer cachexia: nursing assessment

92 Cachexia: Quality of Life references Bennani-Baiti N et al., What is cancer anorexia-cachexia syndrome? A historical perspective. J R Coll Physicians Edinb 2009;39: Fearon KC et al.,understanding the mechanisms and treatment options in cancer cachexia. Nat Rev Clin Oncol 2013;10:90 9. Vaughan VC et al., Cancer cachexia: impact, mechanisms and emerging treatments. J Cachexia Sarcopenia Muscle 2013;4: Fearon KC et al., Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011;12: Tan BH, Fearon KC., Cachexia: prevalence and impact in medicine. Curr Opin Clin Nutr Metab Care 2008;11: Fearon KC et al., Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab 2012;16: Dodson S, et al., Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies. Annu Rev Med 2011;62:

Session 6: Choosing and using HRQoL measures vs Multi-Attribute Utility Instruments QLU-C10D and EQ-5D as examples

Session 6: Choosing and using HRQoL measures vs Multi-Attribute Utility Instruments QLU-C10D and EQ-5D as examples Session 6: Choosing and using HRQoL measures vs Multi-Attribute Utility Instruments QLU-C10D and EQ-5D as examples - Madeleine King & Richard De Abreu Lourenco- Overview Learning Objectives To discuss

More information

Dr Richard Harding. King s College London. BHIVA AUTUMN CONFERENCE 2014 Including CHIVA Parallel Sessions

Dr Richard Harding. King s College London. BHIVA AUTUMN CONFERENCE 2014 Including CHIVA Parallel Sessions BHIVA AUTUMN CONFERENCE 2014 Including CHIVA Parallel Sessions Dr Richard Harding King s College London 9-10 October 2014, Queen Elizabeth II Conference Centre, London BHIVA AUTUMN CONFERENCE 2014 Including

More information

Has Consumer Directed Care improved the quality of life of older Australians? Professor Julie Ratcliffe School of Medicine Flinders University

Has Consumer Directed Care improved the quality of life of older Australians? Professor Julie Ratcliffe School of Medicine Flinders University Has Consumer Directed Care improved the quality of life of older Australians? Professor Julie Ratcliffe School of Medicine Flinders University Acknowledgments: ARC Linkage Project A Health Economics Model

More information

Your Health Survey. Forename: Surname: Renal Unit: Type of treatment: If HD, are you: Date of birth: Home Post Code: Date completed: NHS number:

Your Health Survey. Forename: Surname: Renal Unit: Type of treatment: If HD, are you: Date of birth: Home Post Code: Date completed: NHS number: Your Health Survey Why this questionnaire You may already have heard about renal units introducing health questionnaires. The purpose of these questionnaires is to find out how your kidney disease affects

More information

PATIENT REPORTED OUTCOMES

PATIENT REPORTED OUTCOMES Introduction to Clinical Research: A Two-week Intensive Course PATIENT REPORTED OUTCOMES Albert W. Wu, MD, MPH Overview 1. Importance of patient perspective 2. Definitions 3. Key concepts to measure as

More information

Cancer cachexia: assessment and classification. KCH Fearon University of Edinburgh Scotland

Cancer cachexia: assessment and classification. KCH Fearon University of Edinburgh Scotland Cancer cachexia: assessment and classification KCH Fearon University of Edinburgh Scotland 1 What is the cancer cachexia phenotype?...the shoulders, clavicles, chest and thighs melt away. This illness

More information

Validation of an Arabic Version of the ORWELL97 Questionnaire in Adults with Obesity

Validation of an Arabic Version of the ORWELL97 Questionnaire in Adults with Obesity Validation of an Arabic Version of the ORWELL97 Questionnaire in Adults with Obesity Leila Itani 1, Simona Calugi 2, Dima Kriedieh 1, Germine El Kassas 1, Dana El Masri 1, Hana Tannir 1, Riccardo Della

More information

Improving trial methodology: Examples from epilepsy. Tony Marson University of Liverpool

Improving trial methodology: Examples from epilepsy. Tony Marson University of Liverpool Improving trial methodology: Examples from epilepsy Tony Marson University of Liverpool This talk Examples of trial methodology research Focus on epilepsy but Examples are relevant to any field Epilepsy

More information

KAISER PERMANENTE SPINE

KAISER PERMANENTE SPINE KAISER PERMANENTE SPINE The following forms are specially designed to give your doctor valuable information about the health of your spine. The same way an EKG gives us information about your heart. It

More information

Alexandra Savova, Guenka Petrova. Medical University Sofia Faculty of Pharmacy

Alexandra Savova, Guenka Petrova. Medical University Sofia Faculty of Pharmacy Alexandra Savova, Guenka Petrova. Medical University Sofia Faculty of Pharmacy INTRODUCTION There are three basic goals laying down the therapeutic behavior during the treatment process of hepatitis infection:

More information

Varicose Veins Surgery Questionnaire

Varicose Veins Surgery Questionnaire REV_VaricoseVeins_12pp_Q_PostOp 29/10/09 Page 1 Varicose Veins Surgery Questionnaire After your operation About three months ago you had a Varicose Veins Operation. You may remember that you agreed that

More information

Quality of Life and Survivorship:

Quality of Life and Survivorship: Quality of Life and Survivorship: Implications for Future Ovarian Cancer Research and Care Lari Wenzel, PhD Professor of Medicine & Public Health Associate Director, Population Science and Cancer Control

More information

London Pathway Evaluation

London Pathway Evaluation Digestive Disorders Clinical Academic Unit Endoscopy Unit The Royal London Hospital Whitechapel London E1 1BB Tel: 020 7377 7218 Main switchboard: 020 7377 7000 The Trial Homeless people, outcomes questionnaire

More information

Prof Marion Eckert Rosemary Bryant AO Research Centre

Prof Marion Eckert Rosemary Bryant AO Research Centre Willingness of cancer survivors to complete patient reported outcomes (PRO) surveys: a pilot study at Flinders Centre for Innovation in Cancer (FCIC), South Australia Prof Marion Eckert Rosemary Bryant

More information

The usefulness of EuroQol and McGill Quality of Life questionnaires in palliative care in-patients

The usefulness of EuroQol and McGill Quality of Life questionnaires in palliative care in-patients The usefulness of EuroQol and McGill Quality of Life questionnaires in palliative care in-patients Ewa Deskur-Smielecka, Bogusław Stelcer, Aleksandra Kotlinska-Lemieszek, Katarzyna Wieczorowska-Tobis Poznan

More information

Are touchscreen computer surveys acceptable to medical oncology patients?

Are touchscreen computer surveys acceptable to medical oncology patients? Southern Cross University epublications@scu School of Education 1997 Are touchscreen computer surveys acceptable to medical oncology patients? Sallie Newell Southern Cross University Rob William Sanson-Fisher

More information

Food for thought. Department of Health Services Research 1

Food for thought. Department of Health Services Research 1 Food for thought Suppose you have been asked to undertake an economic evaluation of the costs and effects on the Fall prevention program Identify the range of different costs that you might wish to include

More information

Health Technology Assessment (HTA)

Health Technology Assessment (HTA) Health Technology Assessment (HTA) Determination of utilities for the QLQ-C30 Georg Kemmler, Eva Gamper, Bernhard Holzner Department for Psychiatry and Psychotherapy Innsbruck Medical University Austria

More information

Patient reported outcome measures (PROMs) in HIV

Patient reported outcome measures (PROMs) in HIV WHO Collaborating Centre Patient reported outcome measures (PROMs) in HIV Dr Katherine Bristowe Cicely Saunders Institute King s College London Competing or Conflicting Interests None. Background: problems

More information

Patient Details Hidden. Clinical Enrollment. Quality of Life. EuroQOL (EQ-5D) Enroll Patient. Not Started. Not Started

Patient Details Hidden. Clinical Enrollment. Quality of Life. EuroQOL (EQ-5D) Enroll Patient. Not Started. Not Started Patient Details Hidden Show Patient Clinical Enrollment t Started Quality of Life t Started EuroQOL (EQ-5D) Did the patient complete a EuroQOL form? Please select a reason why the EuroQOL was not completed:

More information

Becoming Food Aware in Hospital Strategies to improve food intake and the nutrition care culture

Becoming Food Aware in Hospital Strategies to improve food intake and the nutrition care culture Becoming Food Aware in Hospital Strategies to improve food intake and the nutrition care culture Malnutrition Morbidity Wound healing Infections Complications Convalescence Mortality Treatment Length of

More information

Analysis of Patient Reported Outcomes Measures

Analysis of Patient Reported Outcomes Measures Analysis of Patient Reported Outcomes Measures Pre-Operative Health Status Data April 2009 to March 2010 Commissioning Analysis and Intelligence & System Management and New Enterprise DH Information Reader

More information

Background. 2 5/30/2017 Company Confidential 2015 Eli Lilly and Company

Background. 2 5/30/2017 Company Confidential 2015 Eli Lilly and Company May 2017 Estimating the effects of patient-reported outcome (PRO) diarrhea and pain measures on PRO fatigue: data analysis from a phase 2 study of abemaciclib monotherapy, a CDK4 and CDK6 inhibitor, in

More information

Measuring health-related quality of life in persons with dementia DOMS results & recommendations

Measuring health-related quality of life in persons with dementia DOMS results & recommendations Measuring health-related quality of life in persons with dementia DOMS results & recommendations Madeleine King, Siggi Zapart, Jan Sansoni, Nick Marosszeky On behalf of the Dementia Outcomes Measurement

More information

Nutritional requirements in advanced cancer patients

Nutritional requirements in advanced cancer patients Nutritional requirements in advanced cancer patients Paula Ravasco p.ravasco@fmedicina.ulisboa.pt Laboratory of Nutrition Faculty of Medicine of the University of Lisbon Medical School of Lisbon Portugal

More information

Women s Health Development Unit, School of Medical Science, Health Campus, Universiti Sains Malaysia b

Women s Health Development Unit, School of Medical Science, Health Campus, Universiti Sains Malaysia b The Malay Version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC-QLQ C30): Reliability and Validity Study Yusoff N a, Low WY b and Yip CH c ORIGINAL

More information

A new era of therapeutics for cancer cachexia. Cachexia is a continuum with 3 stages of clinical relevance

A new era of therapeutics for cancer cachexia. Cachexia is a continuum with 3 stages of clinical relevance A new era of therapeutics for cancer cachexia I. Depletion of Reserves II. Limitation of food intake III. Catabolic Drivers IV. Impact and outcomes Vickie Baracos PhD Professor and Alberta Cancer Foundation

More information

Appendix D- Review of instruments assessing health-related quality of life

Appendix D- Review of instruments assessing health-related quality of life Appendix D- Review of instruments assessing health-related quality of life Excerpted from A review of approaches and instruments for assessing health-related quality of life Tulane University / Horizons

More information

Development of a patient-reported outcomes measure (PROM) for NASH that meets regulatory standards

Development of a patient-reported outcomes measure (PROM) for NASH that meets regulatory standards Development of a patient-reported outcomes measure (PROM) for NASH that meets regulatory standards Dr. Maria-Magdalena Balp Director Health Economics & Outcomes Research Novartis Pharma AG This presentation

More information

QUALITY OF LIFE IN CANCER CLINICAL TRIALS A Practical Guide For. Research Staff

QUALITY OF LIFE IN CANCER CLINICAL TRIALS A Practical Guide For. Research Staff QUALITY OF LIFE IN CANCER CLINICAL TRIALS A Practical Guide For Research Staff Contents What is Quality of Life?.. 1 QOL in Cancer Trials. 2 How is QOL Measured?....3 EORTC Questionnaires.....4 FACIT Questionnaires..

More information

Quality of Life. The assessment, analysis and reporting of patient-reported outcomes. Third Edition

Quality of Life. The assessment, analysis and reporting of patient-reported outcomes. Third Edition Quality of Life The assessment, analysis and reporting of patient-reported outcomes Third Edition PETER M. FAYERS Institute of Applied Health Sciences, University ofaberdeen School of Medicine and Dentistry,

More information

Qu est-ce que la santé? Regard critique sur les QALYs et analyse d autres paramètres pour mesurer les gains en santé

Qu est-ce que la santé? Regard critique sur les QALYs et analyse d autres paramètres pour mesurer les gains en santé Chaire Francqui: leçon 5 Qu est-ce que la santé? Regard critique sur les QALYs et analyse d autres paramètres pour mesurer les gains en santé Lieven Annemans ULB, 17 mai 2017 The goal of health care systems

More information

Introducing the QLU-C10D A preference-based utility measure derived from the QLQ-C30

Introducing the QLU-C10D A preference-based utility measure derived from the QLQ-C30 Introducing the QLU-C10D A preference-based utility measure derived from the QLQ-C30 Presented by Professor Madeleine King Cancer Australia Chair in Cancer Quality of Life Faculties of Science and Medicine

More information

Table of Contents. Preface to the third edition xiii. Preface to the second edition xv. Preface to the fi rst edition xvii. List of abbreviations xix

Table of Contents. Preface to the third edition xiii. Preface to the second edition xv. Preface to the fi rst edition xvii. List of abbreviations xix Table of Contents Preface to the third edition xiii Preface to the second edition xv Preface to the fi rst edition xvii List of abbreviations xix PART 1 Developing and Validating Instruments for Assessing

More information

The Chinese University of Hong Kong The Nethersole School of Nursing. CADENZA Training Programme

The Chinese University of Hong Kong The Nethersole School of Nursing. CADENZA Training Programme The Chinese University of Hong Kong The Nethersole School of Nursing CTP003 Chronic Disease Management and End-of-life Care Web-based Course for Professional Social and Health Care Workers Copyright 2012

More information

An update from the HISTORIC initiative

An update from the HISTORIC initiative DEPARTMENT OF DERMATOLOGY, ROSKILDE, DENMARK An update from the HISTORIC initiative Linnea Thorlacius, MD, PhD student CSG-COUSIN, Berlin, January 9 DEPARTMENT OF DERMATOLOGY, ROSKILDE HOSPITAL, DENMARK

More information

LIHS Mini Master Class

LIHS Mini Master Class Alexandru Nicusor Matei 2013 CC BY-NC-ND 2.0 Measurement and valuation of health using QALYS John O Dwyer Academic Unit of Health Economics John O Dwyer University of Leeds 2015. This work is made available

More information

Alberta PROMs & EQ-5D Research & Support Unit (APERSU): A Brief Introduction. Dr. Jeff Johnson January 30, 2016

Alberta PROMs & EQ-5D Research & Support Unit (APERSU): A Brief Introduction. Dr. Jeff Johnson January 30, 2016 Alberta PROMs & EQ-5D Research & Support Unit (APERSU): A Brief Introduction Dr. Jeff Johnson January 30, 2016 Faculty/Presenter Disclosure Faculty: Jeff Johnson Relationships with commercial interests:

More information

WHO Quality of Life. health other than the cause of a disease or the side effects that come along with it. These other

WHO Quality of Life. health other than the cause of a disease or the side effects that come along with it. These other WHO Quality of Life Overview of the WHO Quality of Life As healthcare progresses globally, so does that evolution of scientific research on healthcare assessments and practices. Healthcare services have

More information

KAISER PERMANENTE SPINE

KAISER PERMANENTE SPINE KAISER PERMANENTE SPINE The following forms are specially designed to give your doctor valuable information about the health of your spine. The same way an EKG gives us information about your heart. It

More information

This is a repository copy of Health-related quality of life after treatment for bladder cancer in England.

This is a repository copy of Health-related quality of life after treatment for bladder cancer in England. This is a repository copy of Health-related quality of life after treatment for bladder cancer in England. White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/130368/ Version:

More information

Measuring health related quality of life in persons with dementia

Measuring health related quality of life in persons with dementia University of Wollongong Research Online Australian Health Services Research Institute Faculty of Business 2008 Measuring health related quality of life in persons with dementia Madeleine King University

More information

An Introduction to Costeffectiveness

An Introduction to Costeffectiveness Health Economics: An Introduction to Costeffectiveness Analysis Subhash Pokhrel, PhD Reader in Health Economics Director, Division of Health Sciences Why do we need economic evaluation? 2017 2 Patient

More information

LupusPRO (Lupus Patient Reported Outcome Tool) v1.7

LupusPRO (Lupus Patient Reported Outcome Tool) v1.7 LupusPRO (Lupus Patient Reported Outcome Tool) v1.7 Authors: Meenakshi Jolly and Simon Pickard For information on, or permission to use tool, please contact: Meenakshi Jolly, MD Assistant Professor of

More information

Initial assessment of patients without cognitive failure admitted to palliative care: a validation study

Initial assessment of patients without cognitive failure admitted to palliative care: a validation study Original Article Initial assessment of patients without cognitive failure admitted to palliative care: a validation study José António Ferraz Gonçalves 1, Clara Castro 2, Paula Silva 1, Rui Carneiro 1,

More information

NICE DSU TECHNICAL SUPPORT DOCUMENT 8: AN INTRODUCTION TO THE MEASUREMENT AND VALUATION OF HEALTH FOR NICE SUBMISSIONS

NICE DSU TECHNICAL SUPPORT DOCUMENT 8: AN INTRODUCTION TO THE MEASUREMENT AND VALUATION OF HEALTH FOR NICE SUBMISSIONS NICE DSU TECHNICAL SUPPORT DOCUMENT 8: AN INTRODUCTION TO THE MEASUREMENT AND VALUATION OF HEALTH FOR NICE SUBMISSIONS REPORT BY THE DECISION SUPPORT UNIT August 2011 John Brazier 1 and Louise Longworth

More information

Instruments Available for Use in Assessment Center

Instruments Available for Use in Assessment Center Instruments Available for Use in Assessment Center The Assessment Center Instrument Library includes instruments from PROMIS, Neuro-QoL, NIH Toolbox and Health LiTT. All instruments are available for use

More information

COSMIN methodology for assessing the content validity of PROMs. User manual

COSMIN methodology for assessing the content validity of PROMs. User manual COSMIN methodology for assessing the content validity of PROMs User manual version 1.0 Caroline B Terwee Cecilia AC Prinsen Alessandro Chiarotto Henrica CW de Vet Lex M Bouter Jordi Alonso Marjan J Westerman

More information

Background. Workshop. Using the WHOQOL in NZ

Background. Workshop. Using the WHOQOL in NZ Using the WHOQOL in NZ Australasian Mental Health Outcomes Conference Workshop Using WHOQOL in New Zealand Prof Rex Billington, Dr Daniel Shepherd, & Dr Chris Krägeloh Rex Billington Chris Krageloh What

More information

Patient Reported Outcomes: are they appropriate for clinical practice? Jose M Valderas Clinical Lecturer

Patient Reported Outcomes: are they appropriate for clinical practice? Jose M Valderas Clinical Lecturer Patient Reported Outcomes: are they appropriate for clinical practice? Jose M Valderas Clinical Lecturer Key issues What are PROMs? Why PROMs? Assessing PROMs Interpreting PROMs Evidence for use in clinical

More information

The Socioeconomic Cost of Chronic Rhinosinusitis (SoCCoR) Study

The Socioeconomic Cost of Chronic Rhinosinusitis (SoCCoR) Study UEA Office Use only Local Ref Please try to fill in ALL parts of the questionnaire, even if you do not have sinus problems and do not feel they are directly relevant to you. The Socioeconomic Cost of Chronic

More information

<</<</<<<< <</<</<<<< < << <<< * * *1* *TCO26* ! No Surgery or Treatment Scheduled Yet

<</<</<<<< <</<</<<<< < << <<< * * *1* *TCO26* ! No Surgery or Treatment Scheduled Yet Cervical Myelopathy Pre-Treatment Form - Twin Cities Orthopedics STICKER FIELD If there is not any sticker available please write the required data below: Patient First Name: Patient Last Name: Medical

More information

For more information: Quality of Life. World Health Organization Definition of Health

For more information: Quality of Life. World Health Organization Definition of Health Health-Related Quality of Life - 10 John E. Ware, Jr., PhD, Professor and Chief Measurement Sciences Division, Department of Quantitative Health Sciences University of Massachusetts Medical School, Worcester,

More information

Please return the questionnaire in the enclosed pre-paid envelope

Please return the questionnaire in the enclosed pre-paid envelope Instructions Please complete the questionnaire, making sure you reply to all the questions. This should take you about 20 minutes. If you have difficulties completing the questionnaire, please ask someone

More information

Single Technology Appraisal (STA) Anamorelin for treating cachexia and anorexia in people with non-small-cell lung cancer

Single Technology Appraisal (STA) Anamorelin for treating cachexia and anorexia in people with non-small-cell lung cancer Single Technology Appraisal (STA) Anamorelin for treating cachexia and anorexia in people with non-small-cell Response to consultee and commentator comments on the draft remit and draft scope (pre-referral)

More information

Patient-Reported Outcomes (PROs) and the Food and Drug Administration Draft Guidance. Donald L. Patrick University of Washington

Patient-Reported Outcomes (PROs) and the Food and Drug Administration Draft Guidance. Donald L. Patrick University of Washington Patient-Reported Outcomes (PROs) and the Food and Drug Administration Draft Guidance Paul-Martini-Stiftung Berlin-Brandenburgische Akademie der Wissenschaften 6 March 2008 10:45 11:05 Donald L. Patrick

More information

The Socioeconomic Cost of Chronic Rhinosinusitis (SoCCoR) Study

The Socioeconomic Cost of Chronic Rhinosinusitis (SoCCoR) Study UEA Office Use only: Patient Indentification umber: Please try to fill in ALL parts of the questionnaire, even if you do not have sinus problems and do not feel they are directly relevant to you. The Socioeconomic

More information

London Pathway Evaluation

London Pathway Evaluation Digestive Disorders Clinical Academic Unit Endoscopy Unit The Royal London Hospital Whitechapel London E1 1BB Tel: 020 7377 7218 Main switchboard: 020 7377 7000 The Trial Homeless people, outcomes questionnaire

More information

alternate-form reliability The degree to which two or more versions of the same test correlate with one another. In clinical studies in which a given function is going to be tested more than once over

More information

Patient Reported Outcomes

Patient Reported Outcomes Date Patient Reported Outcomes Presented by: Ari Gnanasakthy RTI Health Solutions 9 th Feb 2015 RTI Health Solutions Research Triangle Park, NC, USA Ann Arbor, MI, USA Barcelona, Spain Ljungskile, Sweden

More information

RESEARCH ARTICLE. Mozhgan Patoo 1 *, Abbas Ali Allahyari 1 Ali Reza Moradi 2, Mehrdad Payandeh 3. Abstract. Introduction

RESEARCH ARTICLE. Mozhgan Patoo 1 *, Abbas Ali Allahyari 1 Ali Reza Moradi 2, Mehrdad Payandeh 3. Abstract. Introduction DOI:http://dx.doi.org/10.7314/APJCP.2015.16.9.3799 RESEARCH ARTICLE Persian Version of Functional Assessment of Cancer Therapy- Breast (FACT-B) Scale: Confirmatory Factor Analysis and Psychometric Properties

More information

Making a psychometric. Dr Benjamin Cowan- Lecture 9

Making a psychometric. Dr Benjamin Cowan- Lecture 9 Making a psychometric Dr Benjamin Cowan- Lecture 9 What this lecture will cover What is a questionnaire? Development of questionnaires Item development Scale options Scale reliability & validity Factor

More information

The Assessment in Advanced Dementia (PAINAD) Tool developer: Warden V., Hurley, A.C., Volicer, L. Country of origin: USA

The Assessment in Advanced Dementia (PAINAD) Tool developer: Warden V., Hurley, A.C., Volicer, L. Country of origin: USA Tool: The Assessment in Advanced Dementia (PAINAD) Tool developer: Warden V., Hurley, A.C., Volicer, L. Country of origin: USA Conceptualization Panel rating: 1 Purpose Conceptual basis Item Generation

More information

Incorporating the patient voice in sarcoma research:

Incorporating the patient voice in sarcoma research: Incorporating the patient voice in sarcoma research: How can we assess health-related quality of life in this heterogeneous patient groep? Olga Husson PhD Institute of Cancer Research, Division of Clinical

More information

SUPPLEMENT MATERIALS. Appendix A: Cleveland Global Quality of Life (CGQL) [0 being the WORST and 10 being the BEST]

SUPPLEMENT MATERIALS. Appendix A: Cleveland Global Quality of Life (CGQL) [0 being the WORST and 10 being the BEST] SUPPLEMENT MATERIALS Appendix A: Cleveland Global Quality of Life (CGQL) [0 being the WORST and 10 being the BEST] Q1. Current Quality of Life: Circle one 6 7 8 9 10 Q2. Current Quality of Health: Circle

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Cohen DJ, Van Hout B, Serruys PW, et al. Quality of life after

More information

Health-related quality of life a prospective cohort study in phase I oncology trial participants 1

Health-related quality of life a prospective cohort study in phase I oncology trial participants 1 Health-related quality of life a prospective cohort study in phase I oncology trial participants 1 28 August 2018 Diane (A.J.) van der Biessen 2, Wendy H. Oldenmenger, Peer G. van der Helm, Dennis Klein,

More information

The HeartQol questionnaire. Reliability, validity and responsiveness?

The HeartQol questionnaire. Reliability, validity and responsiveness? The HeartQol questionnaire. Reliability, validity and responsiveness? Stefan Höfer, PhD, MSc Associate Professor Medical University Innsbruck The HeartQoL Story Data collection: 2000 2010 Presentations:

More information

The University of Iowa College of Nursing Alzheimer's Family Involvement in Care Study. Caregiver Stress Inventory (CSI) (4-9) (10-13)

The University of Iowa College of Nursing Alzheimer's Family Involvement in Care Study. Caregiver Stress Inventory (CSI) (4-9) (10-13) 1 The University of Iowa College of Nursing Alzheimer's Family Involvement in Care Study Caregiver Stress Inventory (CSI) ID# Date: (4-9) (10-13) DIRECTIONS: Each of the statements in this questionnaire

More information

The QLQ-C30 cut-off project - Symptom screening with the EORTC quality of life scales

The QLQ-C30 cut-off project - Symptom screening with the EORTC quality of life scales The QLQ-C30 cut-off project - Symptom screening with the EORTC quality of life scales Johannes Giesinger Division of Psychosocial Research and Epidemiology The Netherlands Cancer Institute Amsterdam The

More information

Mapping the EORTC QLQ C-30 onto the EQ-5D Instrument: The Potential to Estimate QALYs without Generic Preference Data

Mapping the EORTC QLQ C-30 onto the EQ-5D Instrument: The Potential to Estimate QALYs without Generic Preference Data Volume 12 Number 1 2009 VALUE IN HEALTH Mapping the EORTC QLQ C-30 onto the EQ-5D Instrument: The Potential to Estimate QALYs without Generic Preference Data Lynda McKenzie, MSc, Marjon van der Pol, PhD

More information

CHAPTER 3 RESEARCH METHODOLOGY

CHAPTER 3 RESEARCH METHODOLOGY CHAPTER 3 RESEARCH METHODOLOGY The present study was planned at evaluating the outcomes of pharmacological management of breast cancer in a tertiary care centre in Udupi district of Karnataka, India. An

More information

Sustained employability in cancer survivors: a behavioural approach

Sustained employability in cancer survivors: a behavioural approach Sustained employability in cancer survivors: a behavioural approach Dr. Saskia Duijts VU University Medical Center / Department of Public and Occupational Health The Netherlands Cancer Institute / Division

More information

Resources: Types of dementia

Resources: Types of dementia 1/5 Dementia is an umbrella term for a number of progressive conditions affecting the functioning of the brain. Different types of dementia have different causes. There are a great number of rare forms.

More information

Clinical Nutrition in the 21st Century Malnutrition, sarcopenia and cachexia

Clinical Nutrition in the 21st Century Malnutrition, sarcopenia and cachexia Clinical Nutrition in the 21st Century Malnutrition, sarcopenia and cachexia Stéphane M. Schneider, MD, PhD, FEBGH Professor of Nutrition and ESPEN ECPC Chair In proto-indo-european, Latin and Greek Under

More information

European Association for Cardiovascular Prevention & Rehabilitation (EACPR) A Registered Branch of the ESC

European Association for Cardiovascular Prevention & Rehabilitation (EACPR) A Registered Branch of the ESC Quality of life of cardiac patients in Europe: HeartQoL Project Stefan Höfer The HeartQol Questionnaire: methodological and analytical approaches Patients Treatment Is quality of life important in cardiovascular

More information

Japan Journal of Medicine

Japan Journal of Medicine 29 Japan Journal of Medicine 28; (6): 29-296. doi:.3488/jjm.3 Research article An International comparative Study on EuroQol-5-Dimension Questionnaire (EQ-5D) tariff scores between the and Japan Tsuguo

More information

Dementia Quality of Life (DEMQOL)

Dementia Quality of Life (DEMQOL) This is a Sample version of the Dementia Quality of Life (DEMQOL) The full version of the Dementia Quality of Life (DEMQOL) comes without sample watermark.. The full complete version includes Overview

More information

Recovery trajectories following critical illness: Can we really modify them? Tim Walsh Professor of Critical Care, Edinburgh University

Recovery trajectories following critical illness: Can we really modify them? Tim Walsh Professor of Critical Care, Edinburgh University Recovery trajectories following critical illness: Can we really modify them? Tim Walsh Professor of Critical Care, Edinburgh University Considerations What is the problem? What is the current evidence

More information

SECOND AUSTRALIAN CHILD AND ADOLESCENT SURVEY OF MENTAL HEALTH AND WELLBEING HIGHLIGHTS

SECOND AUSTRALIAN CHILD AND ADOLESCENT SURVEY OF MENTAL HEALTH AND WELLBEING HIGHLIGHTS The Mental Health of Children and Adolescents 3 SECOND AUSTRALIAN CHILD AND ADOLESCENT SURVEY OF MENTAL HEALTH AND WELLBEING HIGHLIGHTS A second national survey of the mental health and wellbeing of Australian

More information

ARTIC PC. Diagnosis & treatment study Diary. Version 1 ( )

ARTIC PC. Diagnosis & treatment study Diary. Version 1 ( ) Patient Study Number: Date of consultation: Month Year ARTIC PC Diagnosis & treatment study Diary Version 1 (09.08.16) Page 1 of 29 INSTRUCTIONS Your doctor or nurse and researchers from the ARTIC-PC study

More information

Mesothelioma Outcomes, Research and Experience survey (MORE Survey).

Mesothelioma Outcomes, Research and Experience survey (MORE Survey). Mesothelioma Outcomes, Research and Experience survey (MORE Survey). Mesothelioma UK would like to invite mesothelioma patients to have the opportunity to describe what their experience of investigations,

More information

Mapping QLQ-C30, HAQ, and MSIS-29 on EQ-5D

Mapping QLQ-C30, HAQ, and MSIS-29 on EQ-5D HEALTH-RELATED QUALITY OF LIFE Mapping QLQ-C30, HAQ, and MSIS-29 on EQ-5D Matthijs M. Versteegh, MA, Annemieke Leunis, MSc, Jolanda J. Luime, PhD, Mike Boggild, MD, MRCP, Carin A. Uyl-de Groot, PhD, Elly

More information

MORECare: A framework for conducting research in palliative care

MORECare: A framework for conducting research in palliative care MORECare: A framework for conducting research in palliative care Nancy Preston International Observatory on End of Life Care School of Nursing, Midwifery and Social Work Methods for evaluating service

More information

A new method of measuring how much anterior tooth alignment means to adolescents

A new method of measuring how much anterior tooth alignment means to adolescents European Journal of Orthodontics 21 (1999) 299 305 1999 European Orthodontic Society A new method of measuring how much anterior tooth alignment means to adolescents D. Fox, E. J. Kay and K. O Brien Department

More information

Assessing Quality of Life in Obesity

Assessing Quality of Life in Obesity Assessing Quality of Life in Obesity Obesity & Mental Health Toronto, June 26-28, 2012 Ronette ( Ronnie ) L. Kolotkin, Ph.D. Owner, Obesity and Quality of Life Consulting Consulting Professor, Duke University

More information

QOL-CI: Development & Clinical U7lity of a Pediatric Quality of Life Instrument

QOL-CI: Development & Clinical U7lity of a Pediatric Quality of Life Instrument QOL-CI: Development & Clinical U7lity of a Pediatric Quality of Life Instrument Ive$e Cejas, PhD Department of Otolaryngology University Of Miami 3/8/18 Conflict of Interest AG Bell Board of Directors

More information

Edmonton Symptom Assessment System (ESAS r) Objectives

Edmonton Symptom Assessment System (ESAS r) Objectives Edmonton Symptom Assessment System (ESAS r) Lyn Ceronsky DNP, GNP, FPCN lceronsky@gmail.com December 11, 2018 Objectives Explore the use of Edmonton Symptom Assessment System (ESAS r) tool in clinical

More information

Ingvar Bosaeus, MD, Sahlgrenska University Hospital, Goteborg, Sweden

Ingvar Bosaeus, MD, Sahlgrenska University Hospital, Goteborg, Sweden Cachexia in Cancer Ingvar Bosaeus, MD, Sahlgrenska University Hospital, Goteborg, Sweden Severe, progressive malnutrition and wasting often is seen in advanced cancer, with weight loss long associated

More information

QOLRAD QUESTIONNAIRE FOR PATIENTS WITH GASTROINTESTINAL SYMPTOMS PLEASE READ THIS CAREFULLY BEFORE ANSWERING THE QUESTIONS

QOLRAD QUESTIONNAIRE FOR PATIENTS WITH GASTROINTESTINAL SYMPTOMS PLEASE READ THIS CAREFULLY BEFORE ANSWERING THE QUESTIONS QOLRAD QUESTIONNAIRE FOR PATIENTS WITH GASTROINTESTINAL SYMPTOMS PLEASE READ THIS CAREFULLY BEFORE ANSWERING THE QUESTIONS On the following pages you will find some questions asking about how you have

More information

Primary Care Tool for Assessment of Depression during Pregnancy and Postpartum

Primary Care Tool for Assessment of Depression during Pregnancy and Postpartum HRSA-UIC Assessment of Depression Perinatal during Pregnancy Project: and Postpartum Primary Care Tool for Assessment of Depression during Pregnancy and Postpartum te to health care provider: This tool

More information

Good. Poor [ ] [ ] Yes, at all [ A ] Moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf [ ] [ ]

Good. Poor [ ] [ ] Yes, at all [ A ] Moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf [ ] [ ] PATIENT I.D. This survey asks for your views about your health. This information will help keep track of how you feel and how well you are able to do your usual activities. For each of the following questions,

More information

Chapter 2 A Guide to PROMs Methodology and Selection Criteria

Chapter 2 A Guide to PROMs Methodology and Selection Criteria Chapter 2 A Guide to PROMs Methodology and Selection Criteria Maha El Gaafary Introduction In general, medical management outcomes can be classified into clinical (e.g., cure, survival), personal (e.g.,

More information

ESPEN Congress Geneva 2014 LLL LIVE COURSE: NUTRITIONAL SUPPORT IN CANCER. Multimodal therapy of cancer cachexia K. Fearon (UK)

ESPEN Congress Geneva 2014 LLL LIVE COURSE: NUTRITIONAL SUPPORT IN CANCER. Multimodal therapy of cancer cachexia K. Fearon (UK) ESPEN Congress Geneva 2014 LLL LIVE COURSE: NUTRITIONAL SUPPORT IN CANCER Multimodal therapy of cancer cachexia K. Fearon (UK) Multimodal therapy for cancer cachexia KCH Fearon Learning objectives Understand

More information

PRO ASSESSMENT IN CANCER TRIALS. Emiliano Calvo, Anita Margulies, Eric Raymond, Ian Tannock, Nadia Harbeck and Lonneke van de Poll-Franse

PRO ASSESSMENT IN CANCER TRIALS. Emiliano Calvo, Anita Margulies, Eric Raymond, Ian Tannock, Nadia Harbeck and Lonneke van de Poll-Franse PRO ASSESSMENT IN CANCER TRIALS Emiliano Calvo, Anita Margulies, Eric Raymond, Ian Tannock, Nadia Harbeck and Lonneke van de Poll-Franse DISCLOSURES Emiliano Calvo has reported no conflicts of interest

More information

Community and Mental Health Services. Palliative Care. Criteria and

Community and Mental Health Services. Palliative Care. Criteria and Community and Mental Health Services Specialist Palliative Care Service Referral Criteria and Guidance November 2018 Specialist Palliative Care Service Referrals These guidelines cover referrals for patients

More information

MALIGNANT CACHEXIA (CACHEXIA ANOREXIA SYNDROME): Overview

MALIGNANT CACHEXIA (CACHEXIA ANOREXIA SYNDROME): Overview MALIGNANT CACHEXIA (CACHEXIA ANOREXIA SYNDROME): Overview UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DISCIPLINE OF BIOCHEMISTRY & MOLECULAR BIOLOGY PBL MBBS II SEMINAR VJ Temple 1 Cachexia:

More information

Neuropathic pain (pain due to nerve damage)

Neuropathic pain (pain due to nerve damage) Neuropathic pain (pain due to nerve damage) Clinical Guideline Pain can be nociceptive, neuropathic or mixed. The neuropathic component of pain generally responds poorly to conventional analgesics. Consider

More information

Validation of the Russian version of the Quality of Life-Rheumatoid Arthritis Scale (QOL-RA Scale)

Validation of the Russian version of the Quality of Life-Rheumatoid Arthritis Scale (QOL-RA Scale) Advances in Medical Sciences Vol. 54(1) 2009 pp 27-31 DOI: 10.2478/v10039-009-0012-9 Medical University of Bialystok, Poland Validation of the Russian version of the Quality of Life-Rheumatoid Arthritis

More information

Friday Poster Discussion. Heather Wakelee, MD Stanford University Stanford Cancer Institute

Friday Poster Discussion. Heather Wakelee, MD Stanford University Stanford Cancer Institute Friday Poster Discussion Heather Wakelee, MD Stanford University Stanford Cancer Institute Posters DR. STEINER- PREVALENCE AND IMPACT OF HYPOGONADISM IN CANCER PATIENTS WITH MUSCLE WASTING IN A PHASE IIB

More information